Peripheral T-cell lymphoma

Common Name(s)

Peripheral T-cell lymphoma

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Peripheral T-cell lymphoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Peripheral T-cell lymphoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Peripheral T-cell lymphoma" returned 161 free, full-text research articles on human participants. First 3 results:

Hepatosplenic T-cell lymphoma appearing in the peripheral blood.
 

Author(s): Minoru Kojima, Hiromichi Matsushita

Journal: Blood. 2013 Aug;122(7):1103.

 

Last Updated: 3 Oct 2013

Go To URL
Isolated post-transplantation lymphoproliferative disease involving the breast and axilla as peripheral T-cell lymphoma.
 

Author(s): Ji-Young Hwang, Eun Suk Cha, Jee Eun Lee, Sun Hee Sung

Journal: Korean J Radiol. ;14(5):718-22.

 

Post-transplantation lymphoproliferative disorders (PTLDs) are a heterogeneous group of diseases that represent serious complications following immunosuppressive therapy for solid organ or hematopoietic-cell recipients. In contrast to B-cell PTLD, T-cell PTLD is less frequent and ...

Last Updated: 17 Sep 2013

Go To URL
Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) with hemophagocytosis (HPS): successful treatment using high-dose chemotherapy (BFM-NHL & ALL-90) and autologous peripheral blood stem cell transplantation.
 

Author(s): Eiichi Sakurai, Takashi Satoh, Yashima-Abo Akiko, Chihaya Maesawa, Kanako Tsunoda, Mikiya Endo, Toshihide Akasaka, Tomoyuki Masuda

Journal: J Clin Exp Hematop. 2013 ;53(2):135-40.

 

Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare form of non-Hodgkin lymphoma, in which lymphoma cells infiltrate preferentially into subcutaneous adipose tissue. Although various treatment trials for SPTCL have been attempted, no standardized therapy has been established. ...

Last Updated: 2 Sep 2013

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Peripheral T-cell lymphoma" returned 12 free, full-text review articles on human participants. First 3 results:

Autologous stem cell transplantation as the first-line treatment for peripheral T cell lymphoma: results of a comprehensive meta-analysis.
 

Author(s): J Yin, J Wei, J H Xu, Y Xiao, Y C Zhang

Journal: Acta Haematol.. 2014 ;131(2):114-25.

 

In view of the poor prognosis of most peripheral T cell lymphoma (PTCL) subtypes treated with conventional chemotherapy such as CHOP/CHOP-like regimens, high-dose chemotherapy followed by autologous stem cell transplantation (HDT/ASCT) seems a reasonable option in eligible patients. ...

Last Updated: 21 Feb 2014

Go To URL
Novel targeted therapies in peripheral T cell lymphoma.
 

Author(s): Deepa Jagadeesh, Mitchell R Smith

Journal: Discov Med. 2013 Jun;15(85):367-78.

 

Peripheral T cell lymphomas (PTCL), non-Hodgkin lymphomas characterized by having features of T cells that have matured in the thymus, are a heterogeneous group of clinical entities. Compared with B cell lymphomas, they are less common, more difficult to diagnose and classify, more ...

Last Updated: 3 Jul 2013

Go To URL
Should patients with aggressive peripheral T-cell lymphoma all be treated the same?: no... well yes, ...but maybe not for long.
 

Author(s): Alison J Moskowitz, Matthew A Lunning, Steven M Horwitz

Journal: Cancer J. ;18(5):445-9.

 

The peripheral T-cell lymphomas represent about 15% to 20% of non-Hodgkin lymphomas and are marked by clinical and pathologic heterogeneity. The most common T-cell entities include peripheral T-cell lymphoma, not otherwise specified, angioimmunoblastic T-cell lymphoma, and anaplastic ...

Last Updated: 25 Sep 2012

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma
 

Status: Recruiting

Condition Summary: Relapsed Peripheral T-Cell Lymphoma; Refractory Peripheral T-Cell Lymphoma

 

Last Updated: 23 Jul 2013

Go to URL
Phase 2, Single Arm, Open Label Study of Folotyn in Combination With Oral Leucovorin to Prevent or Reduce Mucositis in Patients With PTCL
 

Status: Recruiting

Condition Summary: Relapsed Peripheral T-Cell Lymphoma; Refractory Peripheral T-Cell Lymphoma

 

Last Updated: 12 Aug 2014

Go to URL
Treatment of Peripheral T-cell Lymphoma
 

Status: Recruiting

Condition Summary: Peripheral T-cell Lymphoma

 

Last Updated: 19 Sep 2013

Go to URL